NAD+ decline with age: what the research measures
NAD+ supports hundreds of cellular reactions and sirtuin activity. Studies report lower levels with age, but a 2026 replication study has questioned how universal that decline is.
Read article →For research use only — not for human consumption
Journal · Page 3
Peptide research notes from Senna Research: mechanisms, published studies, analytical testing and handling, for laboratory research use only.
NAD+ supports hundreds of cellular reactions and sirtuin activity. Studies report lower levels with age, but a 2026 replication study has questioned how universal that decline is.
Read article →Notes on the groundwork of peptide research: how material is stored, what the evidence does and does not support, and why unglamorous results deserve attention.
Read article →Senescent cells survive by holding p53 in the nucleus through FOXO4. FOXO4-DRI is a decoy peptide designed to break that bond in preclinical models.
Read article →First isolated from human plasma in 1973, GHK-Cu has a gene-expression profile that is directional, not random, and plasma levels that fall by about 60% with age.
Read article →GLP-1 research now reaches well beyond weight. Notes on where the field is heading and the variables that make combination studies hard to control.
Read article →A purity number is only as good as the chromatogram behind it. Notes on HPLC traces, batch QC and why a few percentage points change an experiment.
Read article →GLP-1 is often described as an appetite signal. Receptor expression data from cardiac and brain tissue suggests the signal reaches much further.
Read article →Mandatory research disclaimer
All materials on this site are sold as laboratory reagents for research use only. They are not drugs, foods, cosmetics, dietary supplements, or medical devices, and are not for human or veterinary use of any kind.
Senna Research makes no claims of safety or efficacy and provides no usage, dosing, or preparation guidance; we publish analytical data only.
These materials have not been evaluated or approved by the U.S. Food and Drug Administration for any use.